Mucositis: The impact, biology and therapeutic opportunities of oral mucositis

This publication has 39 references indexed in Scilit:

• Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial
  Bone Marrow Transplantation, 2008
• Patient‐reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy
  Cancer, 2008
• Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis
  Cancer, 2008
• Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis
  Annals of Oncology, 2006
• Mucositis guidelines: what have they achieved, and where to from here?
  Supportive Care in Cancer, 2006
• Cytokines in head and neck cancer
  Cytokine & Growth Factor Reviews, 2006
• Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers?
  Nature Clinical Practice Oncology, 2005
• Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation
  Bone Marrow Transplantation, 2005
• Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
  New England Journal of Medicine, 2004
• TNF polymorphisms are associated with toxic but not with aGVHD complications in the recipients of allogeneic sibling haematopoietic stem cell transplantation
  Bone Marrow Transplantation, 2003